Vielight Inc. is a pioneering neurotechnology company that develops innovative photobiomodulation (PBM) devices—commonly known as “red light therapy”—to support brain health and mental well-being. Using near-infrared light (NIR), Vielight technology stimulates mitochondrial energy metabolism and neuroplasticity, providing a non-invasive, home-use solution to enhance cognitive function, emotional balance, and overall vitality.

While regulatory approvals for specific neurological conditions are pending, clinical and preclinical studies have demonstrated PBM’s potential benefits in traumatic brain injury, dementia, long COVID-related brain fog, Parkinson’s disease, and autism. Vielight is engaged in over 100 researchers globally, spanning clinical trials, sports performance optimization, and mindfulness studies. The company also conducts cellular and mechanistic research to deepen understanding of PBM effects and guide continuous device innovation.

Vielight’s next generation of technologies integrates artificial intelligence for personalized neuromodulation, representing the future of accessible, data-driven brain care. With more than 100,000 devices distributed worldwide to clinicians and consumers, Vielight is a leader in advancing brain health through light.

Dr. Lew Lim, founder and CEO, will present at eMHIC 2025, sharing insights on PBM’s role in digital and home-based mental health innovation.